TCRT-PGEN Fundamental & Technical Discussion Board - The UK-based company thatís striving to overcome the limitations of T cell receptor innovation - TCRT-PGEN Fundamental & Technical Discussion Board - InvestorVillage


TCRT-PGEN Fundamental & Technical Discussion Board
This is a semi-private group. You are free to browse messages, but you must be a member of this group to post messages. Join This Group

Group: TCRT-PGEN Fundamental & Technical Discussion Board   /  Message Board  /  Read Message

 
 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  27767 of 28474  at  5/25/2022 8:29:00 PM  by

dachmeister4u


 In response to msg 27763 by  dnmun
view thread

Re: The UK-based company thatís striving to overcome the limitations of T cell receptor innovation

I greatly appreciate your statements of the lead that Rosenberg and Deniger have set up for Alaunos -- the very essence of success -- a comprehensive, automated interrogation and "capture" of each patient's neoantigen profiles.

I agree that elevated positive measurement of the "living drug" in the first metastatic cancer patient over several weeks should gain attention. In tandem with scans in September, there should be a wake-up. After all, first or millionth -- the blueprint's design process is the same ... (against an unmet need!). Thanks.



     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 20  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board


Financial Market Data provided by
.
Loading...